Devices & Diagnostics CEO: $270M acquisition of US Endoscopy is STERIS’ “most significant deal … in many years” By
Devices & Diagnostics STERIS sees new fiscal year as ‘turning point’ as it completes System 1 transition By Brandon Glenn
Devices & Diagnostics STERIS launches new biodecontamination device for life sciences customers By Brandon Glenn
Devices & Diagnostics STERIS gets 510(k) clearance on software modification to liquid sterilization system By Brandon Glenn
Devices & Diagnostics STERIS customers get another six months for System 1 transition By Brandon Glenn
Devices & Diagnostics STERIS still awaiting FDA clearance of key accessory to System 1E device By Brandon Glenn
Devices & Diagnostics STERIS launches new version of low-temperature sterilization system By Brandon Glenn
Devices & Diagnostics Healthcare jobs: STERIS looking to hire 50, particularly engineers By Brandon Glenn